People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tyrogenex, Inc. | — | Biotechnology | Series A | $14.6M | $19.7M | 2016 |
Adam Goodfriend at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adam Goodfriend on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Brady | 1 | 7 |
| Michael Webb | 1 | 6 |
| Vinzenz Ploerer | 1 | 4 |
| SHERIDAN G. SNYDER | 1 | 3 |
| DENNIS L. PALMGREN | 1 | 2 |
| SHERIDAN D. SNYDER | 1 | 2 |
| TERI A. SWIFT | 1 | 1 |
| CHRIS D. LIANG | 1 | 1 |
| DENNIS A. PALMGREN | 1 | 1 |
| Chris Liang | 1 | 1 |
| Sheridan Snyder | 1 | 1 |
| John Irwin III | 1 | 1 |
| Cheryl Calhoun | 1 | 1 |
| Joseph Straight | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.